All Cancer Microbiology articles
-
NewsTwo transcription factors reproduce the beneficial side of a ‘Jekyll and Hyde’ viral protein
Scientists have traced key antitumor immune effects of LMP1, a cancer-promoting Epstein-Barr virus protein, to two transcription factors, Spi-B and IRF1, and found that expressing the two together made tumor cells easier for the immune system to recognize and better able to activate CD8+ T cells without using the viral protein itself.
-
NewsResearchers develop dual-action bacterial cancer therapy
Tumors that resist immune attack, recur, and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents. Addressing this, researchers developed an engineered strain of Salmonella Typhimurium carrying two anticancer components.
-
NewsEngineered Salmonella kills tumours. A salt-triggered gel keeps it from poisoning the mice
In mice with melanoma, the hydrogel matched free bacteria at shrinking tumours while cutting weight loss by 82% and reversing liver and spleen damage; it sets in seconds on sodium already present in the abdomen.
-
NewsGut microbe remote-controls breast cancer — and one enzyme switch can cut the connection
A multidisciplinary team identifies Ruminococcus lactaris as a key tumor-promoting gut bacterium that produces UDP-GlcNAc to hijack the host O-GlcNAcylation system, driving breast cancer progression via an OGT–NFIB–KIT positive-feedback loop.
-
NewsResearchers harness the microbiome to prevent deadly bloodstream infections
Researchers have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens.
-
NewsWho actually benefits from H. pylori treatment? A genetic score can tell before the first pill
In two Chinese randomized trials, a genetic score built from 11 variants identified people whose gastric cancer risk fell 56%–80% after Helicobacter pylori eradication — cutting the number needed to treat from 112 to 43.
-
NewsHPV-driven cell death pathways offer new directions for cervical cancer treatment
A new review proposes that PCD in cervical cancer should be understood not as a series of isolated pathways, but as an interconnected regulatory network that governs both tumor behavior and therapeutic sensitivity.
-
NewsTargeting the gut-liver axis: New review explores microbial modulation to enhance immunotherapy in hepatocellular carcinoma
A review examines how gut microbiota and their metabolites reshape the hepatic immune microenvironment through the gut–liver axis, influence immune checkpoint inhibitor efficacy, and explore emerging combination strategies, including fecal microbiota transplantation, probiotics, engineered bacteria, and metabolite-based interventions.
-
NewsCan better gut health help patients with ovarian cancer tolerate chemotherapy?
A new clinical trial is testing whether probiotics can help patients with ovarian cancer better tolerate chemotherapy. The trial will look at whether probiotics can help reduce treatment side effects and improve quality of life. Researchers will also study how changes in the gut microbiome may be linked to treatment response.
-
News‘Hiding in plain sight’ - new bacteria discovered in DNA samples from prostate cancer patients
Researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients. Most came from the mouth, including new types of Porphyromonas, which the team has previously linked to more aggressive prostate cancer, and Treponema.
-
NewsHuman papillomavirus: Can we finally predict which infections will progress to cancer?
Infection with human papillomavirus (HPV) is extremely common and, in the vast majority of cases, clears up on its own. However, in some people, it persists and can develop into precancerous lesions or even cancer. How can these high-risk situations be identified at an early stage?
-
NewsFree webinar: How living conditions can shape microbiomes
A fascinating free webinar will reveal how microbiomes are not based only on biology - but how we live. ‘Microbiomes, Inequity, and Structural Conditions: Rethinking What Shapes Health’ underlines that microbiomes don’t exist in isolation — they reflect the systems we live in.
-
NewsStudy finds Helicobacter pylori exposure may be associated with more than one in five colorectal cancer cases worldwide
An international collaborative research study has found that exposure to Helicobacter pylori, a bacterium known to cause stomach ulcers and gastric cancer, may be associated with approximately 22% of colorectal cancer cases globally.
-
NewsLong-term viral hepatitis control and changing patterns of liver cancer mortality in Japan
A review paper investigated how coordinated policy frameworks and robust epidemiological infrastructure have been associated with reductions in viral hepatitis–related HCC in Japan, and what gaps remain toward achieving hepatitis elimination.
-
NewsOncolytic viruses and CAR cells team up against solid tumors
Oncolytic viruses and CAR-T or CAR-NK cells could be engineered together to overcome some of the biggest barriers in solid tumor treatment. A new review outlines how these therapies may be combined into programmable systems that improve tumor targeting, immune-cell infiltration and sustained antitumor activity.
-
NewsModel traces C. diff spread in hospital oncology units
In a new study, researchers modeled the transmission of Clostridioides difficile infections among patients in hospital cancer units. They found that most new infections were introduced by patients who were infected but not symptomatic at the time of admission, rather than by patients who were infected and symptomatic.
-
NewsNew genetic platform could pave the way for better HPV vaccines
Scientists have developed a new genetic platform that could pave the way for more stable, efficient and widely available HPV vaccines, helping address persistent global shortages. The approach allows researchers to generate and select promising virus variants with traits that could improve future vaccine production and storage.
-
NewsScientists mine fragmented data for antibiotics and cancer treatments
Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data. Through this work, the researchers identified and prioritized promising natural-product candidates with potential antibacterial or anticancer activity.
-
NewsSugar amplifies damage done to gut health by antibiotics
Eating sweets while taking antibiotics may worsen the harm done by the drugs to the normal community of bacteria in the gut, a new study has found. The study of hospitalized cancer patients found an additional 21% reduction in the variety of helpful bacterial species present for every 100 grams of sugar consumed in the 48 hours before treatment.
-
NewsPneumonia can reveal undiagnosed blood cancer
Severe pneumococcal disease requiring hospitalization, most commonly pneumonia, can be a sign of previously undiagnosed blood cancer and immunodeficiency in adult patients, according to a study.